Velcade FDA Approval History
FDA Approved: Yes (First approved May 13, 2003)
Brand name: Velcade
Generic name: bortezomib
Dosage form: for Injection
Company: Millennium Pharmaceuticals
Treatment for: Multiple Myeloma
Velcade is an antineoplastic agent indicated for the treatment of multiple myeloma and mantle cell lymphoma.
Development timeline for Velcade
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.